Biogen completes acquisition of Apellis Pharmaceuticals - Ophthalmology Times
HealthcareMerger
Biogen→Apellis Pharmaceuticals
May 18, 2026
Track ophthalmology acquisitions and investments within the healthcare sector.
Biogen→Apellis Pharmaceuticals
May 18, 2026
PRISM Vision Group→Retina Macula Institute
May 13, 2026
Brightstar Capital Partners→Simon Eye
May 12, 2026
Bayer→Perfuse Therapeutics
May 6, 2026
Artemis→Optikos
May 1, 2026
MyEyeDr→Lumina Vision Partners
Apr 24, 2026
Cencora→EyeSouth Retina Business
Apr 6, 2026
Lupin→VISUfarma
Apr 1, 2026
Vision Innovation Partners→Frederick Eye Institute
Mar 30, 2026
VIP→Frederick Eye Institute
Mar 30, 2026
Cencora→EyeSouth Retina
Mar 27, 2026
Cencora
Mar 23, 2026
Cencora→EyeSouth Partners
Mar 23, 2026
Alcon Research→LENSAR
Mar 17, 2026
Axol Bioscience→Newcells Biotech ophthalmology business
Feb 18, 2026